Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Researchers study the effects of alcohol intake and seek better treatment for alcoholic pancreatitis

Researchers study the effects of alcohol intake and seek better treatment for alcoholic pancreatitis

Duke biomedical engineers develop a two-pronged approach to treating pancreatic cancer

Duke biomedical engineers develop a two-pronged approach to treating pancreatic cancer

Cedars Sinai experts remind men of their breast cancer risk

Cedars Sinai experts remind men of their breast cancer risk

Two small molecules reverse pancreatic acinar ductal metaplasia

Two small molecules reverse pancreatic acinar ductal metaplasia

Salk's three collaborative projects win 2022 Curebound Discovery Grant

Salk's three collaborative projects win 2022 Curebound Discovery Grant

Common oral bacterium promotes tumor progression-associated activity in pancreatic cancer cells

Common oral bacterium promotes tumor progression-associated activity in pancreatic cancer cells

Mic60-low gene signature may be a simple tool to estimate pancreatic cancer risk

Mic60-low gene signature may be a simple tool to estimate pancreatic cancer risk

Protoporphyrin IX delayed fluorescence imaging as a modality for hypoxia-based oncologic surgical guidance

Protoporphyrin IX delayed fluorescence imaging as a modality for hypoxia-based oncologic surgical guidance

CT and MRI scans fail to detect many pancreatic cancer cases, study reveals

CT and MRI scans fail to detect many pancreatic cancer cases, study reveals

Study reveals an increase in the prevalence of digestive diseases

Study reveals an increase in the prevalence of digestive diseases

Study links pancreatic cancer survival outcomes with arrangement of immune cells in tumors

Study links pancreatic cancer survival outcomes with arrangement of immune cells in tumors

Research may lead to safer ways to care for patients impacted by blood clots

Research may lead to safer ways to care for patients impacted by blood clots

Newly discovered gene marker may lead to a precision treatment for pancreatic cancer

Newly discovered gene marker may lead to a precision treatment for pancreatic cancer

Overload of stress granules enables the growth of obesity-related pancreatic cancer

Overload of stress granules enables the growth of obesity-related pancreatic cancer

Sugar-sweetened beverages increase risk of death from obesity-related cancer

Sugar-sweetened beverages increase risk of death from obesity-related cancer

AI used to identify pancreatic cancer in CT scans

AI used to identify pancreatic cancer in CT scans

Deep learning tool highly effective at detecting pancreatic cancer on CT

Deep learning tool highly effective at detecting pancreatic cancer on CT

Study investigates the efficacy and safety of selpercatinib in a diverse group of patients

Study investigates the efficacy and safety of selpercatinib in a diverse group of patients

Phase I/II LIBRETTO-001 trial: RET inhibitor achieves durable objective responses across multiple tumors

Phase I/II LIBRETTO-001 trial: RET inhibitor achieves durable objective responses across multiple tumors

Study provides a potential game-changer in assessing treatment response in pancreatic cancer patients

Study provides a potential game-changer in assessing treatment response in pancreatic cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.